» Articles » PMID: 28341641

Proliferation of Latently Infected CD4 T Cells Carrying Replication-competent HIV-1: Potential Role in Latent Reservoir Dynamics

Overview
Journal J Exp Med
Date 2017 Mar 26
PMID 28341641
Citations 262
Authors
Affiliations
Soon will be listed here.
Abstract

A latent reservoir for HIV-1 in resting CD4 T lymphocytes precludes cure. Mechanisms underlying reservoir stability are unclear. Recent studies suggest an unexpected degree of infected cell proliferation in vivo. T cell activation drives proliferation but also reverses latency, resulting in productive infection that generally leads to cell death. In this study, we show that latently infected cells can proliferate in response to mitogens without producing virus, generating progeny cells that can release infectious virus. Thus, assays relying on one round of activation underestimate reservoir size. Sequencing of independent clonal isolates of replication-competent virus revealed that 57% had sequences identical to other isolates from the same patient. Identity was confirmed by full-genome sequencing and was not attributable to limited viral diversity. Phylogenetic and statistical analysis suggested that identical sequences arose from in vivo proliferation of infected cells, rather than infection of multiple cells by a dominant viral species. The possibility that much of the reservoir arises by cell proliferation presents challenges to cure.

Citing Articles

HIV-1 Rebound Virus Consists of a Small Number of Lineages That Entered the Reservoir Close to ART Initiation.

Tyers L, Moeser M, Ntuli J, Council O, Zhou S, Spielvogel E bioRxiv. 2025; .

PMID: 39975202 PMC: 11838395. DOI: 10.1101/2025.01.29.635391.


Cognate antigen engagement induces HIV-1 expression in latently infected CD4 T cells from people on long-term antiretroviral therapy.

Moskovljevic M, Dragoni F, Board N, Wu F, Lai J, Zhang H Immunity. 2024; 57(12):2928-2944.e6.

PMID: 39612916 PMC: 11896817. DOI: 10.1016/j.immuni.2024.11.002.


HIV-1 diversity in viral reservoirs obtained from circulating T-cell subsets during early ART and beyond.

Zhang Y, Otte F, Stoeckle M, Thielen A, Daumer M, Kaiser R PLoS Pathog. 2024; 20(9):e1012526.

PMID: 39292732 PMC: 11410260. DOI: 10.1371/journal.ppat.1012526.


Transcription of HIV-1 at sites of intact latent provirus integration.

Teixeira A, Bittar C, Silva Santos G, Oliveira T, Huang A, Linden N J Exp Med. 2024; 221(9).

PMID: 39141127 PMC: 11323366. DOI: 10.1084/jem.20240391.


Advancing Toward a Human Immunodeficiency Virus Cure: Initial Progress on a Difficult Path.

Margolis D Infect Dis Clin North Am. 2024; 38(3):487-497.

PMID: 38969530 PMC: 11410351. DOI: 10.1016/j.idc.2024.06.001.


References
1.
Han Y, Lin Y, An W, Xu J, Yang H, OConnell K . Orientation-dependent regulation of integrated HIV-1 expression by host gene transcriptional readthrough. Cell Host Microbe. 2008; 4(2):134-46. PMC: 2604135. DOI: 10.1016/j.chom.2008.06.008. View

2.
Scripture-Adams D, Brooks D, Korin Y, Zack J . Interleukin-7 induces expression of latent human immunodeficiency virus type 1 with minimal effects on T-cell phenotype. J Virol. 2002; 76(24):13077-82. PMC: 136703. DOI: 10.1128/jvi.76.24.13077-13082.2002. View

3.
Chomont N, El-Far M, Ancuta P, Trautmann L, Procopio F, Yassine-Diab B . HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med. 2009; 15(8):893-900. PMC: 2859814. DOI: 10.1038/nm.1972. View

4.
Mansky L, Temin H . Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol. 1995; 69(8):5087-94. PMC: 189326. DOI: 10.1128/JVI.69.8.5087-5094.1995. View

5.
Chun T, Stuyver L, Mizell S, Ehler L, Mican J, Baseler M . Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci U S A. 1997; 94(24):13193-7. PMC: 24285. DOI: 10.1073/pnas.94.24.13193. View